Impact of Treating Severe Periodontitis on Inflammatory Activity of Atheromatous Plaques in Patients With Acute Myocardial Infarction (AMI)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-70
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

Multicenter randomized clinical trial with two arms in patients hospitalized for an AMI nested in the Frenchie registry. Periodontal therapy is performed by periodontists in the intervention group versus treatment by dental surgeons as part of their usual practice in the control group.

For the intervention group, periodontal management will be carried out for a maximum of 6 months after randomisation, prolonged by a follow-up of 6 months including a maintenance visit at M9.

All patients will have an FDG-PET at M0 and M12 for evaluation of inflammation on carotid atherosclerotic plaques.

Eligibility criteria

Qualifiers

Patients hospitalized for an acute myocardial infarction and included in the Frenchie registry

Score ≥ 5 on the screening questionnaire for periodontitis

Six teeth at least (excluding wisdom teeth)

Consent signature

Disqualifiers

Patients with diseases,other than cardiovascular and diabetes, known to change the periodontal state such as AIDS, rheumatoid arthritis, Chediak-Higashi syndrome, Papillon-Lefèvre

Systemic antibiotic therapy> 48 hours in the 3 months prior to inclusion

Acute heart failure

Uncontrolled ventricular rhythm disorders

Trial design

Treatments tested in this trial

  • Periodontal treatment

Treatment groups

210 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Assistance Publique - Hôpitaux de Paris

Lead sponsor

National Research Agency, France

Collaborator